Rathbun, A. M.
Magaziner, J.
Shardell, M. D.
Yerges-Armstrong, L. M.
Orwig, D.
Hicks, G. E.
Hochberg, M. C.
Funding for this research was provided by:
National Institute on Aging (R37 AG009901)
National Institute on Aging (R01 AG029315)
National Institute on Aging (P30 AG028747, T32 AG000262)
Article History
Received: 16 July 2017
Accepted: 16 October 2017
First Online: 24 October 2017
Compliance with ethical standards
:
: Jay Magaziner has consulting agreements with Ammonett, Novartis, and Pluristem. Denise Orwig has consulting agreements with Viking Therapeutics, Inc. Laura M. Yerges-Armstrong is a statistical geneticist at GlaxoSmithKline. Drs. Alan M. Rathbun, Michelle D. Shardell, Gregory E. Hicks, and Marc C. Hochberg have no disclosures to declare.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individuals participants included in the study.